356 related articles for article (PubMed ID: 25381882)
1. Hereditary breast cancer syndromes and genetic testing.
Rich TA; Woodson AH; Litton J; Arun B
J Surg Oncol; 2015 Jan; 111(1):66-80. PubMed ID: 25381882
[TBL] [Abstract][Full Text] [Related]
2. Genetic testing by cancer site: breast.
Shannon KM; Chittenden A
Cancer J; 2012; 18(4):310-9. PubMed ID: 22846731
[TBL] [Abstract][Full Text] [Related]
3. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
[TBL] [Abstract][Full Text] [Related]
4. Breast Cancer: Genetics and Risk Assessment.
Tejada-Bergés T
Clin Obstet Gynecol; 2016 Dec; 59(4):673-687. PubMed ID: 27749364
[TBL] [Abstract][Full Text] [Related]
5. Breast Cancer Genetics for the Surgeon: An Update on Causes and Testing Options.
Grignol VP; Agnese DM
J Am Coll Surg; 2016 May; 222(5):906-14. PubMed ID: 26968323
[No Abstract] [Full Text] [Related]
6. Gene panel testing for inherited cancer risk.
Hall MJ; Forman AD; Pilarski R; Wiesner G; Giri VN
J Natl Compr Canc Netw; 2014 Sep; 12(9):1339-46. PubMed ID: 25190699
[TBL] [Abstract][Full Text] [Related]
7. [Risk assessment for familial occurrence of breast cancer].
Chang-Claude J; Becher H; Hamann U; Schroeder-Kurth T
Zentralbl Gynakol; 1995; 117(8):423-34. PubMed ID: 7571905
[TBL] [Abstract][Full Text] [Related]
8. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
9. Genetic testing for cancer predisposition.
Eng C; Hampel H; de la Chapelle A
Annu Rev Med; 2001; 52():371-400. PubMed ID: 11160785
[TBL] [Abstract][Full Text] [Related]
10. Genetic predisposition syndromes and their management.
Euhus DM; Robinson L
Surg Clin North Am; 2013 Apr; 93(2):341-62. PubMed ID: 23464690
[TBL] [Abstract][Full Text] [Related]
11. Hereditary cancer syndromes.
Fostira F; Thodi G; Konstantopoulou I; Sandaltzopoulos R; Yannoukakos D
J BUON; 2007 Sep; 12 Suppl 1():S13-22. PubMed ID: 17935271
[TBL] [Abstract][Full Text] [Related]
12. Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels.
Feliubadaló L; López-Fernández A; Pineda M; Díez O; Del Valle J; Gutiérrez-Enríquez S; Teulé A; González S; Stjepanovic N; Salinas M; Capellá G; Brunet J; Lázaro C; Balmaña J;
Int J Cancer; 2019 Nov; 145(10):2682-2691. PubMed ID: 30927264
[TBL] [Abstract][Full Text] [Related]
13. Hereditary cancer syndromes, their testing and prevention.
Foretová L
Cas Lek Cesk; 2019; 158(1):15-21. PubMed ID: 31046387
[TBL] [Abstract][Full Text] [Related]
14. Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast Cancer.
Chang-Claude J; Becher H; Caligo M; Eccles D; Evans G; Haites N; Hodgson S; Møller P; Weber BH; Stoppa-Lyonnet D
Dis Markers; 1999 Oct; 15(1-3):53-65. PubMed ID: 10595253
[TBL] [Abstract][Full Text] [Related]
15. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
[TBL] [Abstract][Full Text] [Related]
16. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
Daly MB; Pilarski R; Yurgelun MB; Berry MP; Buys SS; Dickson P; Domchek SM; Elkhanany A; Friedman S; Garber JE; Goggins M; Hutton ML; Khan S; Klein C; Kohlmann W; Kurian AW; Laronga C; Litton JK; Mak JS; Menendez CS; Merajver SD; Norquist BS; Offit K; Pal T; Pederson HJ; Reiser G; Shannon KM; Visvanathan K; Weitzel JN; Wick MJ; Wisinski KB; Dwyer MA; Darlow SD
J Natl Compr Canc Netw; 2020 Apr; 18(4):380-391. PubMed ID: 32259785
[TBL] [Abstract][Full Text] [Related]
17. Multi-Gene Panel Testing of 23,179 Individuals for Hereditary Cancer Risk Identifies Pathogenic Variant Carriers Missed by Current Genetic Testing Guidelines.
Neben CL; Zimmer AD; Stedden W; van den Akker J; O'Connor R; Chan RC; Chen E; Tan Z; Leon A; Ji J; Topper S; Zhou AY
J Mol Diagn; 2019 Jul; 21(4):646-657. PubMed ID: 31201024
[TBL] [Abstract][Full Text] [Related]
18. [Molecular genetics of hereditary breast carcinoma].
Hampl M; Chang-Claude J; Schwarz P; Saeger HD; Schackert HK
Zentralbl Chir; 1997; 122(2):67-73. PubMed ID: 9173760
[TBL] [Abstract][Full Text] [Related]
19. Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.
Drohan B; Roche CA; Cusack JC; Hughes KS
Ann Surg Oncol; 2012 Jun; 19(6):1732-7. PubMed ID: 22427173
[TBL] [Abstract][Full Text] [Related]
20. Genetic testing and prevention of hereditary cancer at the MMCI--over 10 years of experience.
Foretova L; Petrakova K; Palacova M; Kalabova R; Svoboda M; Navratilova M; Schneiderova M; Bolcak K; Krejci E; Drazan L; Mikova M; Hazova J; Vasickova P; Machackova E
Klin Onkol; 2010; 23(6):388-400. PubMed ID: 21348412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
